Hostname: page-component-7479d7b7d-pfhbr Total loading time: 0 Render date: 2024-07-15T20:24:42.028Z Has data issue: false hasContentIssue false

Is there a difference in prevalence of anxiety and depression symptoms among patients with different stages of hypertension?

Published online by Cambridge University Press:  23 March 2020

A. Mermerelis*
Affiliation:
2nd Psychiatric Clinic Athens University, Attikon Hospital, Athens, Greece
S.M. Kyvelou
Affiliation:
1st Cardiology Clinic Athens University, Cardiology Clinic, Athens, Greece
V. Akke
Affiliation:
Epidemiology Department Galway university Hospital, Epidemiology, Galway, Ireland
C. Papageorgiou
Affiliation:
1st Psychiatric Clinic Athens University, Aiginition Hospital, Athens, Greece
C. Stefanadis
Affiliation:
1st Cardiology Clinic Athens University, Hippokration Hospital, Athens, Greece
A. Douzenis
Affiliation:
2nd Psychiatric Clinic Athens University, Attikon Hospital, Athens, Greece
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Whether anxiety and depression are associated with hypertension and to what extent is not clear.

Aims

The aim of the present study was to assess any differences in the prevalence of anxiety and depression among different groups of hypertensive patients.

Methods

The study cohort comprised of 127 patients (75 male, mean age 54 ± 14) who underwent assessment of their blood pressure levels and were divided in four groups: group I (normotensives, n = 34), group II (stage 1 HTN, n = 33), group III (stage 2 HTN, n = 30) and group IV (stage 3 HTN, n = 30). The evaluation of anxiety disorder was made by means of Hospital Anxiety Depression Scale (HADS), while the evaluation of depression was made with the Beck Depression Inventory (BDI). Statistical analysis was done with SPSS for windows. P-value was set at 0.05 for differences to be considered significant.

Results

Comparing the four groups of patients there was a significant difference both in BDI (8.6 ± 7.0 vs. 11.6 ± 10.4 vs. 27.1 ± 5.8 vs. 32.4 ± 3.9, P < 0.0001) and HADS (10.2 ± 7.2 vs. 9.7 ± 7.0 vs. 16 ± 4.7 vs. 27 ± 5.1, P < 0.0001). We proceeded to comparison among the 4 groups and there was a significant rise in the BDI and HADS in three of the four groups group II > group III > group IV, P < 0.0001.

Conclusion

These data suggest that there is a clear burden of anxiety and depression as the levels of BP increase. This finding is of important clinical significance as it could contribute to a different approach of hypertensive patients. A larger cohort study could enlightened the mechanisms involved.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster viewing: anxiety disorders and somatoform disorders
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.